3-O-Methylquercetin More Selectively Inhibits Phosphodiesterase Subtype 3

Abstract

Rhamnus nakaharai Hayata (Rhamnaceae), has been used as a folk medicine in Taiwan for treating constipation, inflammation, tumors and asthma. 3-O-Methylquercetin (3-MQ), a main constituent of the plant, has been reported to inhibit total cAMP- and cGMP-phosphodiesterase (PDE) of guinea pig trachealis. Therefore we were interested in investigating the inhibitory effect of 3-MQ on various PDE isozymes from guinea pig lungs and hearts. Isolated guinea pig lungs and hearts were homogenized and centrifuged. The supernatant was chromatographed over a column of Q-sepharose, and eluted with various concentrations of NaCl. In the following order, PDE subtypes 1, 5, 2, 4 from lungs, and 3 from hearts were separated. The IC₅₀ values of 3-MQ on these isozymes were 31.9, 86.9, 18.6, 28.5 and 1.6 μM, respectively. 3-MQ (10 - 100 μM) non-competitively inhibited PDE2, but competitively inhibited PDE4. 3-MQ (1 - 10 μM) also competitively inhibited PDE3. However, 3-MQ (10 - 100 μM) did not competitively inhibit PDE1 and 5, although it had a tendency to competitively inhibit PDE1 at concentrations of 10 - 30 μM. The present results showed that K_i value of 3-MQ was similar to that of milrinone in PDE3, and was not significantly different from that of Ro 20 - 1724 in PDE4, respectively. In conclusion, 3-MQ was revealed to be a selective and competitive PDE3/PDE4 inhibitor, although its inhibitory effect on PDE4 was not potent. Therefore, 3-MQ may have a potential in the treatment of asthma beside its antiviral activity.

Abbreviations

3-MQ:3-O-methylquercetin

PDE:phosphodiesterase

cAMP:adenosine 3′,5′ cyclic monophosphate

cGMP:guanosine 3′,5′ cyclic monophosphate

EGTA:ethylene glycol-bis(β-aminoethyl ether), N,N,N′,N′-tetraacetic acid

EDTA:ethylenediaminetetraacetic acid

BSA:bovine serum albumin

PMSF:phenylmethanesulfonyl fluoride

EHNA:erythro-9-(2-hydroxy-3-nonyl)-adenine HCl

Ro 20-1724:4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

Key words

3-O-Methylquercetin - Rhamnus nakaharai - Rhamnaceae - guinea pig - phosphodiesterase - isozymes

References

• 1 Giembycz M A. Phosphodiesterase 4 inhibitors and the treatment of asthma.  Drugs. 2000;  59 193-212
• 2 Torphy T J, Cieslinski L B. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.  Molecular Pharmacology. 1990;  37 206-14
• 3 Kapui Z, Schaeffer P, Mikus E G, Boronkay E, Gyürky J, Herbert J M, Pascal M. Experimental studies on guanosine 3′,5′-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265 579 in guinea-pigs.  Arzneimittel-Forschung. 1999;  49 685-93
• 4 De Boer J, Philpott A J, van Amsterdam R G, Shahid M, Zaagsma J, Nicholson C D. Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors.  British Journal of Pharmacology. 1992;  106 1028-34
• 5 Silver P J, Hamel L T, Perrone M H, Bentley R G, Bushover C R, Evans D B. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle.  European Journal of Pharmacology. 1988;  150 85-94
• 6 Underwood D C, Kotzer C J, Bochnowicz S, Osborn R R, Luttmann M A, Hay D WP, Torphy T J. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.  Journal of Pharmacology and Experimental Therapeutics. 1994;  270 250-9
• 7 Chiu N Y, Chang K H. The illustrated medicinal plants of Taiwan. 5 Taipei: SMC. 1998.: P. 135-6
• 8 Ko W C, Wang H L, Lei C B, Shih C H, Chung M I, Lin C N. Mechanisms of relaxant action of 3-O-methylquercetin in isolated guinea pig trachea.  Planta Medica. 2002;  68 30-5
• 9 Lin C N, Lu C M, Lin H C, Ko F N, Teng C M. Novel antiplatelet naphthalene from Rhamnus nakaharai .  Journal of Natural Products. 1995;  58 1934-40
• 10 Thompson W J, Appleman M M. Multiple cyclic nucleotide phosphodiesterase activities from rat brain.  Biochemistry. 1971;  10 311-6
• 11 Ahn H S, Crim W, Romano M, Sybertz E, Pitts B. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta.  Biochemical Pharmacology. 1989;  38 3331-9
• 12 Mery P F, Pavoine C, Pecker F, Fischmeister R. erythro-9-(2-Hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.  Molecular Pharmacology. 1995;  48 121-30
• 13 Harrison S A, Reifsnyder D H, Gallis B, Cadd G G, Beavo J A. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.  Molecular Pharmacology. 1986;  29 506-14
• 14 Sheppard H, Wiggan G, Tsien W H. Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.  Advances in Cyclic Nucleotide Research. 1972;  1 103-12
• 15 Gillespie P G, Beavo J A. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.  Molecular Pharmacology. 1989;  36 773-81
• 16 Bradford M M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.  Analytical Chemistry. 1976;  72 248-54
• 17 Wei B L, Lu C M, Tsao L T, Wang J P, Lin C N. In vitro anti-inflammatory effects of quercetin 3-O-methyl ether and other constituents from Rhamnus species.  Planta Medica. 2001;  67 745-7
• 18 Cimanga K, Ying L, De Bruyne T, Apers S, Cos P, Hermans N, Bakana P, Tona L, Kambu K, Kalenda D T, Pieters L, Vanden Berghe D, Vlietinck A J. Radical scavenging and xanthine oxidase inhibitory activity of phenolic compounds from Bridelia ferruginea stem bark.  Journal of Pharmacy and Pharmacology. 2001;  53 757-61
• 19 Laekeman G M, Claeys M, Rwangabo P C, Herman A G, Vlietinck A J. Cardiovascular effects of 3-methylquercetin.  Planta Medica. 1986;  6 433-7
• 20 Vrijsen R, Everaert L, Van Hoof L M, Vlietinck A J, Vanden Berghe D A, Boeye A. The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis.  Antiviral Research. 1987;  7 35-42